Background The DASH (Dietary Approaches to Stop Hypertension) diet is a carbohydrate-rich, reduced-fat diet that lowers blood pressure (BP) and LDL-cholesterol. Whether partial replacement of some carbohydrate (C) with either protein (P) or unsaturated fat (U) can further improve these and other cardiovascular (CVD) risk factors is unknown.
Methods OmniHeart is a randomized, three-period, crossover feeding study designed to compare the effects on BP and blood lipids of a carbohydrate-rich diet (CARB, similar to the DASH diet) with a diet rich in protein (PROT, predominantly from nonmeat sources) and a diet rich in unsaturated fat (UNSAT, predominantly monounsaturated). Throughout feeding (run in and the three intervention periods), participants are provided with all of their meals that meet the nutrient profile of their assigned diet. Calorie intake is adjusted to maintain weight. The target sample size is 160 (50% African-American). Participants are adults, aged 30 or older, with prehypertension or Stage 1 hypertension (systolic BP 120–159 or diastolic BP 80–99 mmHg). The primary outcome variables are systolic BP and LDL-cholesterol. Secondary outcomes are diastolic BP, HDL-cholesterol, and triglycerides. Other outcome variables are total cholesterol, apolipoproteins VLDL-apoB, VLDL-apoCIII, apolipoprotein B, non-HDL cholesterol, and lipoprotein(a), and insulin resistance, as measured by Homeostasis Model Assessment (HOMA).
Conclusions OMNI-Heart should advance our fundamental knowledge of the effects of diet on both traditional and emerging risk factors, and, in the process, guide policy makers, health care providers and the general public on the relative benefits of carbohydrate, protein, and unsaturated fat as a means to reduce CVD risk.
Get full access to this article
View all access options for this article.
References
1.
1. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension1995; 25: 305–313.
2.
2. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA1993; 269: 3015–3023.
3.
3. Gregg EW, Cadwell BL, Cheng YJ, Cowie CC, Williams DE, Geiss L et al. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S.Diabetes Care2004; 27: 2806–2812.
4.
4. Trumbo P, Schlicker S, Yates AA, Poos M. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc2002; 102: 1621–1630.
5.
5. Connor WE, Connor SL. Should a low-fat, high-carbohydrate diet be recommended for everyone? The case for a low-fat, high-carbohydrate diet. N Engl J Med1997; 337: 562–563; discussion 566–567.
6.
6. Krauss RM, Deckelbaum RJ, Ernst N, Fisher E, Howard BV, Knopp RH et al. Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association. Circulation1996; 94: 1795–1800.
7.
7. Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ et al. AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation2000; 102: 2284–2299.
8.
8. Katan MB, Grundy SM, Willett WC. Should a low-fat, high-carbohydrate diet be recommended for everyone? Beyond low-fat diets. N Engl J Med1997; 337: 563–566; discussion 566–567.
9.
9. Obarzanek E, Velletri PA, Cutler JA. Dietary protein and blood pressure. JAMA1996; 275: 1598–1603.
10.
10. Stamler J, Caggiula A, Grandits GA, Kjelsberg M, Cutler JA. Relationship to blood pressure of combinations of dietary macronutrients. Findings of the Multiple Risk Factor Intervention Trial (MRFIT). Circulation1996; 94: 2417–2423.
11.
11. Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Speizer FE et al. Dietary protein and risk of ischemic heart disease in women. Am J Clin Nutr1999; 70: 221–227.
12.
12. Iso H, Stampfer MJ, Manson JE, Rexrode K, Hu F, Hennekens CH et al. Prospective study of fat and protein intake and risk of intraparenchymal hemorrhage in women. Circulation2001; 103: 856–863.
13.
13. He J, Gu D, Wu X, Chen J, Duan X, Whelton PK.Effect of soybean protein on blood pressure: a randomized, controlled trial. Ann Intern Med2005; 143: 1–9.
14.
14. Wolfe BM, Giovannetti PM. Short-term effects of substituting protein for carbohydrate in the diets of moderately hypercholesterolemic human subjects. Metabolism1991; 40: 338–343.
15.
15. Wolfe BM, Giovannetti PM. High protein diet complements resin therapy of familial hypercholesterolemia. Clin Invest Med1992; 15; 349–359.
16.
16. Wolfe BM, Piche LA. Replacement of carbohydrate by protein in a conventional-fat diet reduces cholesterol and triglyceride concentrations in healthy normolipidemic subjects. Clin Invest Med1999; 22: 140–148.
17.
17. Piatti PM, Monti F, Fermo I, Baruffaldi L, Nasser R, Santambrogio G et al. Hypocaloric high-protein diet improves glucose oxidation and spares lean body mass: comparison to hypocaloric high-carbohydrate diet. Metabolism1994; 43: 1481–1487.
18.
18. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G,et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA2004; 292: 1440–1446.
19.
19. Ferrara LA, Raimondi AS, d’Episcopo L, Guida L, Dello Russo A, Marotta T. Olive oil and reduced need for antihypertensive medications. Arch Intern Med2000; 160: 837–842.
20.
20. Strazzullo P, Ferro-Luzzi A, Siani A, Scaccini C, Sette S, Catasta G et al. Changing the Mediterranean diet: effects on blood pressure. J Hypertens1986; 4: 407–412.
21.
21. Morris M, Sacks F. Dietary fats and blood pressure. In: Swales J, ed. Textbook of hypertension, Oxford: Blackwell; 1994, 605–618.
22.
22. National High Blood Pressure Education Program Working Group report on primary prevention of hypertension. Arch Intern Med1993; 153: 186–208.
23.
23. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension2003; 42: 1206–1252.
24.
24. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med2001; 344: 3–10.
25.
25. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med1997; 336: 1117–1124.
26.
26. White WB, Anwar YA. Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Press Monit2001; 6: 107–110.
27.
27. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care2004; 27: 1487–1495.
28.
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia1985; 28: 412–419.
29.
29. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics1982; 38: 963–974.
30.
30. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA2001; 285: 2486–2497.
31.
31. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation1998; 97: 1837–1847.
32.
32. Liao Y, McGee DL, Cooper RS. Prediction of coronary heart disease mortality in blacks and whites: pooled data from two national cohorts. Am J Cardiol1999; 84: 31–36.
33.
33. Chambless LE, Folsom AR, Sharrett AR, Sorlie P, Couper D, Szklo M et al. Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol2003; 56: 880–890.
34.
34. D'Agostino RB, Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA2001; 286: 180–187.
35.
35. Knuiman MW, Vu HT. Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores. J Epidemiol Community Health1997; 51: 515–519.
36.
36. Leaverton PE, Sorlie PD, Kleinman JC, Dannenberg AL, Ingster-Moore L, Kannel WB et al.Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study. J Chronic Dis1987; 40: 775–784.
37.
37. Menotti A, Farchi G, Seccareccia F. The prediction of coronary heart disease mortality as a function of major risk factors in over 30 000 men in the Italian RIFLE pooling Project. A comparison with the MRFIT primary screenees. The RIFLE research group. J Cardiovasc Risk1994; 1: 263–270.
38.
38. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation2002; 105: 310–315.
39.
39. Stamler R. Implications of the INTERSALT study. Hypertension1991; 17: I16–I20.
40.
40. Brancati FL, Appel LJ, Seidler AJ, Whelton PK.Effect of potassium supplementation on blood pressure in African Americans on a low-potassium diet. A randomized, double-blind, placebo-controlled trial. Arch Intern Med1996; 156: 61–67.
41.
41. Ware JH. Interpreting incomplete data in studies of diet and weight loss. N Engl J Med2003; 348: 2136–2137.
42.
42. Rubin DB. Multiple imputation for nonresponse in surveys. New York: J. Wiley; 1987.
